Redgumme,
Is this what you are referring to:
Announcement, date 12 May, 2003:
"Our strategy has always been to continue to build commercial value for PI-88 by providing additional clinical data to optimize value outcomes, with parallel screening of potential licensing partners for the late stage development, registration approval and marketing of PI-88".
Gerry
drug pi-88, melanoma; how good is it?, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.005(1.12%) |
Mkt cap ! $73.30M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.0¢ | 44.5¢ | $88.55K | 198.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 309193 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 266671 | 11 |
View Market Depth
| Last trade - 11.56am 24/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |